GL1X · GenesisL1 explorer

MolNFT v1 · #135861 · protein

TREX2 M-region

5UBP · Leucine permease transcriptional regulator: “TREX2 M-region”. X-ray diffraction, 20 pockets (best druggability 0.68). MolNFT v1 #135861 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5UBP
Type
protein
Length
972 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Leucine permease transcriptional regulator; Nuclear mRNA export protein THP1; 26S…
UniProt
B3LGC5, Q08231, O94742
Pockets
20 · best druggability 0.68

Structure

x-ray diffraction · 3 distinct chains · 59% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALeucine permease transcriptional regulatorprotein46954% helix, 3% strandB3LGC5
BNuclear mRNA export protein THP1protein45565% helix, 2% strandQ08231
C26S proteasome complex subunit SEM1protein4842% helix, 2% strandO94742

Pockets

20 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16800.680.7671empty
23500.610.7839empty
3840.600.8824empty
41870.530.7822empty
51280.520.8122empty

Interfaces

2 interfaces between chains.

  • A–B · 4054 Ų buried · 49 hydrogen bonds · protein-protein
  • B–C · 2414 Ų buried · 39 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5UBP · TREX2 M-region · the same entry in another collection · chain A against A, TM-score 1.00
  • Q08231 · AlphaFold monomer V2.0 prediction for nuclear mRNA export protein THP1 (Q08231) · a predicted model of the same protein · chain B against A, TM-score 0.98
  • O94742 · AlphaFold monomer V2.0 prediction for 26S proteasome complex subunit SEM1 (O94742) · a predicted model of the same protein · chain C against A, TM-score 0.52

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.